PTIX

0.38008.98%
AS

Andrew Slee

Chief Development Officer

Dr. Andrew Slee, also known as Andy, Ph.D. is Chief Development Officer of Protagenic Therapeutics, Inc. from May 15, 2025. He served as Chief Operating Officer at Protagenic Therapeutics, Inc. until May 15, 2025. Dr. Slee served as Development Advisor of Protagenic Therapeutics, Inc. He joined Targanta Therapeutics Corp. in April 2016. During his pharmaceutical career, he has taken several drugs from inception through all their pre-clinical and early clinical testing. He serves as Head of Microbiology & Preclinical Pharmacology at SelectX Pharmaceuticals, Inc. and served as its Vice President of Preclinical Pharmacology and Development. He served as a Consultant and Advisor of SelectX Pharmaceuticals, Inc. He served as Vice President of Pharmacology of Enanta Pharmaceuticals. Prior to joining Enanta, he served as Senior Director of General Pharmacology, Cardiovascular Sciences, Anti-infectives and Research Administration of DuPont Pharmaceuticals Co., since 1995. He has experience in preclinical development and pharmacology. From 1985 to 1995, Dr. Slee served various positions at DuPont Merck Co., including Group Leader of the Chemotherapy and Infectious Diseases Group, Associate Director of Discovery Coordination and Research Administration and also Senior Director of Preclinical Pharmacology and Research Administration. He has worked for Preclinical CROs, immune-oncology companies and natural product companies focusing on anti-infectives, cancer, CNS, diabetes and inflammatory diseases. Spreading his influence beyond a single company, he created and ran his own Contract Research Organization (CRO), VivoSource Laboratories, which from 2003 to 2013 provided preclinical proof of concept catering to biopharmaceutical companies. He shepherded multiple pharma targets in several therapeutic areas from inception onward at DuPont Pharmaceuticals. He served as a Member of Scientific Advisory Board of Targanta Therapeutics Corp. (Targanta Therapeutics Inc.). He was honored with the Alexander Gourevitch Memorial Award in Microbiology at Microbiology at Syracuse University. Dr. Slee earned Doctor of Science degree in Microbiology at Syracuse University. He is a graduate of Syracuse University and Leeds University.

公司职务